ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ZIMMER BIOMET HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$94.99+0.01 (+0.01%)
Close on Oct 19, 2026
- Market cap
- $18.31B
- P/E (TTM)
- 23.1
- Dividend yield
- 1.01%
Zimmer Biomet statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Market Cap | $18.12B | $229.23M |
| Enterprise Value | $25.20B | $194.73M |
| PE Ratio | 23.11 | 33.41 |
| PS Ratio | 2.13 | 3.14 |
| PB Ratio | 1.44 | 3.19 |
| P/FCF Ratio | 11.90 | 27.25 |
| P/OCF Ratio | 10.39 | 22.23 |
Enterprise value
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| EV / Sales | 2.96 | 2.93 |
| EV / EBITDA | 10.89 | 19.97 |
| EV / EBIT | 20.91 | 25.47 |
| EV / FCF | 16.54 | 27.85 |
Income (trailing twelve months)
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Revenue | $8.51B | $102.39M |
| Gross Profit | $5.95B | $60.36M |
| Operating Income | $1.21B | -$4.31M |
| Pretax Income | $933.60M | -$2.26M |
| Net Income | $806.60M | -$6.57M |
| EBITDA | $2.31B | -$1.98M |
| EPS (Diluted) | $4.11 | -$0.07 |
Margins
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Gross Margin | 69.9% | 55.1% |
| Operating Margin | 14.2% | -6.04% |
| Pretax Margin | 11.0% | -4.11% |
| Profit Margin | 9.48% | -10.5% |
| EBITDA Margin | 27.2% | -2.67% |
| FCF Margin | 17.9% | -0.30% |
Returns
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Return on Equity (ROE) | 6.41% | -19.2% |
| Return on Assets (ROA) | 3.53% | -13.3% |
| Return on Invested Capital (ROIC) | 5.31% | -4.11% |
| Return on Capital Employed (ROCE) | 6.09% | -9.07% |
Growth
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 8.62% | 8.85% |
| Net Income Growth (YoY) | -2.04% | 10.6% |
| EPS Growth (YoY) | 0.00% | 10.6% |
| FCF Growth (YoY) | 3.44% | 10.6% |
| Revenue Growth (3Y CAGR) | 5.85% | 7.08% |
| Revenue Growth (5Y CAGR) | 6.08% | 11.8% |
| EPS Growth (3Y CAGR) | 47.8% | 3.06% |
Balance sheet
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $410.00M | $37.33M |
| Total Debt | $7.48B | $72.66M |
| Net Cash (Debt) | -$7.07B | $3.92M |
| Net Cash Per Share | -$37.06 | $0.28 |
| Equity (Book Value) | $12.62B | $57.36M |
| Book Value Per Share | $66.18 | $2.81 |
| Tangible Book Value | -$1.76B | $10.71M |
| Working Capital | $2.08B | $54.64M |
Financial position
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Current Ratio | 1.69 | 2.50 |
| Quick Ratio | 0.72 | 1.54 |
| Debt / Equity | 0.59 | 0.38 |
| Debt / EBITDA | 3.23 | 2.31 |
| Debt / FCF | 4.91 | 3.50 |
| Net Debt / EBITDA | 3.06 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Operating Cash Flow | $1.74B | -$653.46K |
| Capital Expenditures | -$220.30M | -$3.69M |
| Free Cash Flow | $1.52B | -$835.02K |
| FCF Per Share | $7.98 | -$0.02 |
Efficiency
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Asset Turnover | 0.37 | 0.59 |
| Inventory Turnover | 1.09 | 2.21 |
| Revenue Per Employee | $500.52K | $322.75K |
| Profits Per Employee | $47.45K | -$52.11K |
| Employee Count | 17,000 | 197 |
Dividends and yields
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Earnings Yield | 4.45% | -6.92% |
| FCF Yield | 8.41% | -0.62% |
| Dividend Yield | 1.01% | 0.81% |
| Buyback Yield | 4.14% | 0.78% |
| Shareholder Yield | 5.15% | 0.84% |
| Dividend Per Share | $0.96 | $0.72 |
| Dividend Growth (YoY) | 0.00% | 4.80% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 23.4% | 30.3% |
| FCF Payout Ratio | 12.4% | 21.9% |
Shares
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Shares Outstanding | 190,738,000 | 44,856,700 |
| Shares Change (YoY) | -1.97% | 3.35% |
| Float | 190,391,000 | 36,934,400 |
| Shares Held by Insiders | 0.18% | 10.6% |
| Shares Held by Institutions | 104.3% | 63.5% |
Taxes
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Income Tax | $126.60M | $1.52M |
| Effective Tax Rate | 13.6% | 18.6% |
Scores
| Measure | Zimmer Biomet | Industry median |
|---|---|---|
| Graham Number | $78.23 | $34.37 |
| Graham Upside | -17.6% | -58.3% |
| Altman Z-Score | 2.46 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.59 | -2.64 |
Calculated by StockData from Zimmer Biomet's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.